Skip to content
Longterm Wiki
Back

Devex - Coalition for Epidemic Preparedness Innovations

web

This Devex profile of CEPI is tangentially relevant to AI safety discussions around coordination mechanisms for global catastrophic risks, particularly as a case study in international biosecurity governance and multi-stakeholder risk preparedness coordination.

Metadata

Importance: 18/100homepagereference

Summary

This is a Devex organizational profile page for CEPI, a global partnership that finances and coordinates the development of vaccines against epidemic threats. CEPI focuses on accelerating vaccine development for emerging infectious diseases to prevent future pandemics. It serves as a reference entry for understanding CEPI's mission, funding, and partnerships in the global health security space.

Key Points

  • CEPI is a coalition focused on financing and coordinating vaccine development for epidemic and pandemic threats
  • The organization represents a model of international coordination for biological risk preparedness
  • CEPI's work is relevant to biosecurity and global catastrophic biological risk mitigation efforts
  • The Devex profile provides organizational details including funding sources, partners, and key projects
  • CEPI is an example of multi-stakeholder coordination mechanisms for existential and catastrophic risk reduction

Cited by 1 page

Cached Content Preview

HTTP 200Fetched Mar 20, 202612 KB
![](https://res.cloudinary.com/devex/image/asset/devex_logo_original-491891799a4f06a121244aa56d9bbd51.svg)

![Coalition for Epidemic Preparedness Innovations (CEPI)](https://res.cloudinary.com/devex/image/fetch/ar_1:1,b_transparent,c_pad,f_auto,q_auto,w_160/https://neo-assets.s3.amazonaws.com/assets/0135/4133/lgo.jpg)

# Coalition for Epidemic Preparedness Innovations (CEPI)

[Overview](https://www.devex.com/organizations/coalition-for-epidemic-preparedness-innovations-cepi-72733#description-section)

[Jobs](https://www.devex.com/organizations/coalition-for-epidemic-preparedness-innovations-cepi-72733#jobs-section)

[News](https://www.devex.com/organizations/coalition-for-epidemic-preparedness-innovations-cepi-72733#news-section)

[Experience](https://www.devex.com/organizations/coalition-for-epidemic-preparedness-innovations-cepi-72733#experience-section)

[Contact](https://www.devex.com/organizations/coalition-for-epidemic-preparedness-innovations-cepi-72733#contact-section)

## About

CEPI – the Coalition for Epidemic Preparedness Innovations – is a new international non-profit coalition aspiring to build a system that can tackle the barriers to develop vaccines against those epidemic infections for which the usual commercial incentives for development are inadequate. CEPI will advance safe, effective and affordable vaccines that can help to contain outbreaks at the earliest possible stage. CEPI was founded in August 2016 by the Government of Norway, the Bill & Melinda Gates Foundation, the Wellcome Trust, the World Economic Forum, and India’s Department of Biotechnology.

CEPI wants to stop future epidemics by developing new vaccines for a safer world.

Vaccines are one of the world’s most important health achievements. Yet their life-saving potential hasn’t yet been realised for many known and unknown epidemic threats, particularly in low-income countries, where the risks and needs are often greatest.

**Vision**

Vaccines contributing to preventing outbreaks of emerging infectious disease from becoming humanitarian crises.

**Approach**

CEPI will build a new system to advance the development of safe, effective and affordable vaccines, ensuring that price is not a barrier to access for populations most at need. This will offer the world an insurance policy against the growing threat from emerging infectious diseases. CEPI will be a partnership of public, private, philanthropic and civil organisations to stimulate, finance and co-ordinate vaccine development against priority threats, particularly when development is unlikely to occur through market incentives alone.

CEPI will pursue a proactive (“just-in-case”) and accelerated (“just-in-time”) vaccine development strategy for epidemic threats by:

- - Moving vaccine candidates through late preclinical studies to proof of concept and safety in humans before epidemics begin, so that larger effectiveness trials can begin swiftly in an outbreak and small stockpiles are ready for potential emerg

... (truncated, 12 KB total)
Resource ID: df2cfcfed575b98f | Stable ID: MDNlNTIzYT